- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07584837
Cochlear Implantation and Social Outcomes
6. maj 2026 opdateret af: Janet Choi, University of Southern California
The goal of this clinical trial is to learn if hearing devices, like cochlear implants, affect social and cognitive function of older adults. The main questions the researchers want to answer are:
- How social are older adults with hearing loss before and after using hearing devices?
- How well do older adults with hearing loss think before and after using hearing devices?
- For older adults who have hearing loss and use hearing devices, do changes in social interaction explain changes in how well they think (cognitive function)?
- Do brainwaves (EEGs) in older adults with hearing loss change after using hearing devices?
- Are there differences in how social older adults with hearing loss are compared to older adults without hearing loss?
What Participants Will Do:
- Participants will take questionnaires for around 60 minutes. Questionnaires will ask participants about their background, health, hearing, and how social they are. Another set of questionnaires will check their thinking ability or cognition.
- Participants will wear an audio sensor (TILES Audio Recorder on Jelly Mobile phone) for 2 weeks. The sensor will collect and store information about a participant's voice during conversations. Once the device has information about a participant's voice such as pitch and tone it will store this information and delete the audio recording. Words spoken during conversations will be deleted.
- (Optional) Participants can choose to participate in a 45-60-minute EEG (electroencephalogram) recording session. Participants will have sensors placed on top of their heads. Sensors will record the participants' brainwaves. Sounds will be played to see how participants' brainwaves change when they hear sounds. Eligible participants will be invited to participate in 4-month follow-up study.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Anslået)
40
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Janet Choi, MD, MPH
- Telefonnummer: 323-442-5790
- E-mail: janet.choi@med.usc.edu
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90033
- University of Southern California
-
Kontakt:
- Janet Choi, MD, MPH
- Telefonnummer: 323-442-5790
- E-mail: janet.choi@med.usc.edu
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Individuals meeting the inclusion criteria will be recruited from the affiliated tertiary hospitals.
Beskrivelse
Inclusion Criteria:
- Age >= 60 years
- English or Spanish speaking
- older adults with bilateral moderate to profound sensorineural hearing loss who are candidates for cochlear implants or have undergone cochlear implantation.
Exclusion Criteria:
- Age <60 years
- Unable to complete questionnaires in English or Spanish
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Adults with bilateral hearing loss (cochlear implant users or candidates)
Participants with bilateral moderate to profound hearing loss who are candidates for cochlear implant or currently using cochlear implants
|
Participants will undergo or have previously undergone cochlear implantation as part of routine clinical care, independent of this research study.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Audio sensor- speech arousal
Tidsramme: Baseline, optional 4-month follow-up
|
The audio sensor employs deep-learning-based multimodal speech pattern modeling of participants' own voice activities to extract speech arousal and speech activities.
Speech arousal measures include the percentage of strong arousals, serving as a proxy of enhanced engagement in conversations.
|
Baseline, optional 4-month follow-up
|
|
Audio sensor- speech activity
Tidsramme: Baseline, optional 4-month follow-up
|
The audio sensor employs deep-learning-based multimodal speech pattern modeling of participants' own voice activities to extract speech arousal and speech activities.
Speech activity measures include the intersession time (the interval between speech sessions, representing the frequency of conversation engagement).
|
Baseline, optional 4-month follow-up
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
UCLA Loneliness Scale
Tidsramme: Baseline, optional 4 months follow-up
|
The UCLA Loneliness Scale is a 20-item self-report measure assessing subjective feelings of loneliness and social isolation.
Total scores range from 20 to 80, with higher scores indicating greater loneliness and worse outcomes.
Minimum score: 20; maximum score: 80. Higher scores represent worse outcomes.
|
Baseline, optional 4 months follow-up
|
|
Lubben Social Network Scale (LSNS-6)
Tidsramme: Baseline, optional 4 months follow-up
|
The Lubben Social Network Scale (LSNS-6) is a 6-item self-report measure assessing social engagement and perceived social support from family and friends.
Total scores range from 0 to 30, with higher scores indicating larger and more supportive social networks (better outcomes).
Minimum score: 0; maximum score: 30.
Higher scores represent better outcomes.
|
Baseline, optional 4 months follow-up
|
|
Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S)
Tidsramme: Baseline, optional 4 months follow-up
|
The HHIE-S is a 10-item self-report questionnaire assessing the emotional and social/situational effects of hearing loss in older adults.
Total scores range from 0 to 40, with higher scores indicating greater perceived hearing handicap and worse hearing-related quality of life.
Minimum score: 0; maximum score: 40.
Higher scores represent worse outcomes.
|
Baseline, optional 4 months follow-up
|
|
Generalized Anxiety Disorder 7-item (GAD-7) Scale
Tidsramme: Baseline, optional 4 months follow-up
|
The GAD-7 is a 7-item self-report questionnaire assessing the severity of generalized anxiety symptoms over the past two weeks.
Total scores range from 0 to 21, with higher scores indicating greater anxiety severity and worse outcomes.
Minimum score: 0; maximum score: 21.
Higher scores represent worse outcomes.
|
Baseline, optional 4 months follow-up
|
|
Center for Epidemiologic Studies Depression Scale (CES-D)
Tidsramme: Baseline, optional 4 months follow-up
|
The CES-D is a 20-item self-report questionnaire assessing depressive symptoms in the general population over the past week.
Total scores range from 0 to 60, with higher scores indicating greater depressive symptom severity and worse outcomes.
Minimum score: 0; maximum score: 60.
Higher scores represent worse outcomes.
|
Baseline, optional 4 months follow-up
|
|
Cognitive test- MoCA
Tidsramme: Baseline, optional 4-month follow-up
|
Montreal Cognitive Assessment (MoCA) The MoCA is a brief cognitive screening tool assessing multiple domains including memory, attention, executive function, language, visuospatial skills, and orientation.
The standard MoCA total score ranges from 0 to 30, with higher scores indicating better cognitive function (better outcomes).
|
Baseline, optional 4-month follow-up
|
|
EEG Measures
Tidsramme: Baseline, optional 4-month follow-up
|
EEG Event Related Potentials (ERPs) are measures of cortical activities in response to auditory stimuli and provide information about cognitive processing, memory, and attention.
Participants will complete auditory oddball tasks during EEG measurements and ERPs including P1, N1, P2, MMN, P3 will be recorded.
|
Baseline, optional 4-month follow-up
|
|
Duke Social Support Index (DSSI-11)
Tidsramme: Baseline, optional 4-months follow-up
|
The DSSI-11 is an 11-item self-report measure assessing social support across social interaction and subjective support domains.
Total scores range from 10 to 30, with higher scores indicating greater perceived social support (better outcomes).
Minimum score: 10; maximum score: 30.
Higher scores represent better outcomes.
|
Baseline, optional 4-months follow-up
|
|
Short Form Health Survey - 12 Item (SF-12)
Tidsramme: Baseline, optional 4-months follow-up
|
The SF-12 is a 12-item self-report measure assessing overall health-related quality of life across physical and mental domains.
Scores are typically summarized into Physical Component Summary (PCS) and Mental Component Summary (MCS) scores.
When reported as a combined or transformed total score ranging from 0 to 200, higher scores indicate better health-related quality of life (better outcomes).
Minimum score: 0; maximum score: 200.
Higher scores represent better outcomes.
|
Baseline, optional 4-months follow-up
|
|
Short Assessment of Health Literacy (SAHL)
Tidsramme: Baseline, optional 4-months follow-up
|
The SAHL is an 18-item word recognition and comprehension test assessing health literacy.
Total scores range from 0 to 18, with higher scores indicating better health literacy (better outcomes).
Minimum score: 0; maximum score: 18.
Higher scores represent better outcomes.
|
Baseline, optional 4-months follow-up
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. juli 2027
Primær færdiggørelse (Anslået)
31. december 2029
Studieafslutning (Anslået)
31. december 2030
Datoer for studieregistrering
Først indsendt
6. maj 2026
Først indsendt, der opfyldte QC-kriterier
6. maj 2026
Først opslået (Faktiske)
13. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
13. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
6. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neurologiske manifestationer
- Sygdomme i nervesystemet
- Otorhinolaryngologiske sygdomme
- Sensationsforstyrrelser
- Øresygdomme
- Hørelidelser
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Høretab
- Udstyr og forsyninger
- Elektroder
- Elektrisk udstyr og forsyninger
- Elektroder, implanteret
- Proteser og implantater
- Neurale proteser
- Implanterbare neurostimulatorer
- Høreapparater
- Sensoriske hjælpemidler
- Cochleaimplantater
Andre undersøgelses-id-numre
- APP-26-02104
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Høretab, bilateral sensorineural
-
Jessa HospitalRekrutteringHøretab, sensorineural | DFNA9 | Radiologi | Bilateral vestibulær mangelBelgien
-
Jessa HospitalRekrutteringHøretab, sensorineural | DFNA9 | Radiologi | Bilateral vestibulær mangelBelgien
-
Radboud University Medical CenterRekrutteringHøretab, sensorineural | Høretab, bilateralt | Høretab, voksendebut | Høretab, bilateral sensorineural, progressivHolland
-
CochlearAktiv, ikke rekrutterendeHøretab, bilateral sensorineuralAustralien, Frankrig
-
CochlearRekrutteringHøretab, bilateral sensorineuralForenede Stater
-
University of ArizonaRekrutteringHøreapparater | 3D print | Høretab, bilateral sensorineuralForenede Stater
-
University of Wisconsin, MadisonRekrutteringHøretab, voksendebut | Høreapparat | Høretab, bilateral sensorineuralForenede Stater
-
CochlearAvania; QbD ClinicalAktiv, ikke rekrutterendeHøretab, sensorineural | Høretab, bilateralt | Høretab, Cochlear | Høretab, bilateral sensorineuralAustralien, Frankrig, Det Forenede Kongerige, Tyskland
-
University of Southern DenmarkOdense University HospitalAfsluttetPresbycusis, Bilateral
-
Sonova AGAfsluttetHøretab, bilateral sensorineural, progressivSchweiz
Kliniske forsøg med Cochlear implant
-
CochlearAfsluttetEnkeltsidet døvhedForenede Stater
-
Envoy Medical CorporationAktiv, ikke rekrutterendeSensorineuralt høretab | Sensorineuralt høretab (lidelse) | Sensorineuralt høretab, bilateralt | Sensorineuralt høretab, alvorligt | Sensorineuralt høretab, dybt | Sensorisk-neural døvhedForenede Stater
-
Oticon MedicalTrukket tilbageCochleært høretab | Cochleært traume
-
Med-El CorporationAfsluttet
-
Med-El CorporationRekrutteringHøretab, sensorineural | Høretab, ensidigtForenede Stater, Canada
-
CochlearAfsluttetHøretabSpanien, Israel, Frankrig, Italien
-
CochlearAfsluttet
-
University of California, San FranciscoTrukket tilbageDøvhedForenede Stater
-
University of Colorado, DenverAfsluttetHøretab, sensorineuralForenede Stater
-
CochlearNAMSARekrutteringHøretab, ensidigt | Døvhed, ensidigForenede Stater